Molecular subtyping of breast cancer by gene expression has proven its significance in
females. Immunohistochemical surrogates have been used for this classification, because …

Abstract Purpose Male Breast Cancer (MBC) remains a poor understood disease.
Prognostic factors are not well established and specific prognostic subgroups are warranted …

Background Male breast cancer (BC) is rare, managed by extrapolation from female BC. The
International Male BC Program aims to better characterize and manage this disease. We …

Substantial controversy exists about the prognostic role of tumor subtypes in male breast
cancer (MaBC). The aim of this study was to analyze the characteristics of each tumor …

Background. Due to its rarity, male breast cancer (mBC) remains an inadequately
characterized disease, and current evidence for treatment derives from female breast cancer …

Assessment of proliferation is important in female breast cancer and individual treatment
decisions are based upon its results, especially in the luminal subgroups. Gene expression …

The aim of this study is to evaluate the prognostic values of some biological parameters in a
population based series of female breast cancer patients. Through the Tuscan Cancer …

Background To describe relevant pathological parameters of Danish male breast cancer
patients (MBCP) diagnosed from 1980 to 2009, and to relate these data to treatment, overall …

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer
cases worldwide. Due to the low incidence, there are no randomized clinical studies giving …

Breast cancer is the most common cancer form in women and it has been extensively
studied on the molecular level. Male breast cancer (MBC), on the other hand, is rare and has …